Livio Gargantini

FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.

Hematol Oncol 2018 Feb 3;36(1):299-306. Epub 2017 Aug 3.

Commissione Qualità e Risk Management REL, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

View Article and Find Full Text PDF

February 2018

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.

Blood 2015 Aug 18;126(8):950-6. Epub 2015 Jun 18.

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;

View Article and Find Full Text PDF

August 2015

Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.

Authors:

Ercole Brusamolino Chiara Rusconi Luigi Montalbetti Livio Gargantini Lilj Uziel Graziella Pinotti Sergio Fava Luigi Rigacci Guido Pagnucco Cristiana Pascutto Enrica Morra Mario Lazzarino

Haematologica 2006 Apr 15;91(4):496-502. Epub 2006 Mar 15.

Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy.

View Article and Find Full Text PDF

April 2006

Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.

Authors:

Giuliana Muti Catherine Klersy Fausto Baldanti Simonetta Granata Pierluigi Oreste Laura Pezzetti Marta Gatti Livio Gargantini Marianna Caramella Valentina Mancini Guiseppe Gerna Enrica Morra

Br J Haematol 2003 Sep;122(6):927-33

Liver Transplant Unit, Niguarda Hospital, Milan, Italy.

View Article and Find Full Text PDF

September 2003

Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome.

Authors:

Enrico Silini Anna Locasciulli Luca Santoleri Livio Gargantini Giovanbattista Pinzello Marco Montillo Luciana Foti Antonella Lisa Nicola Orfeo Enrico Magliano Annamaria Nosari Enrica Morra

Haematologica 2002 Nov;87(11):1200-8

Department of Pathology, University and IRCCS Policlinico San Matteo, Pavia, Italy.

View Article and Find Full Text PDF

November 2002

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Authors:

Clara Cesana Catherine Klersy Luciana Barbarano Anna Maria Nosari Monica Crugnola Ester Pungolino Livio Gargantini Simonetta Granata Marina Valentini Enrica Morra

J Clin Oncol 2002 Mar;20(6):1625-34

Department of Hematology, Bone Marrow Transplantation Centre, Niguarda Cà Granda Hospital, Milan, Italy.

View Article and Find Full Text PDF

March 2002

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.

Blood 2002 Feb;99(3):856-62

Divisione di Ematologia, Ospedali Riuniti Bergamo, Largo Barozzi 1, 24100 Bergamo, Italy.

View Article and Find Full Text PDF

February 2002

Publications by authors named "Livio Gargantini"

FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.

Authors:

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.

Authors:

Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.

Authors:

Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.

Authors:

Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome.

Authors:

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Authors:

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.

Authors: